
Testicular Cancer: Answering Your Questions
Testicular cancer is a highly treatable disease, with more than 97% of patients cured. More than half of the testicular cancer cases in the United States affect young men between the ages of 15 and 34.
The Testicular Cancer Team at Smilow Cancer Hospital provides compassionate care while offering the most advanced diagnostic, medical and surgical treatments available.
Typically, the most common type of testicular cancer is a germ cell tumor which can be broken down into two categories. One is a seminoma and the other is a non seminoma germ cell tumor. Early diagnosis and treatment are directly related to cure rate, therefore, the our team members strive to ensure a proper diagnosis and treatment plan are established quickly. Testicular cancer patients usually present with a new mass in the testicles that was discovered upon self-exam or at an annual physical. Different types of treatments are available for patients with testicular cancer. These can include:
High-dose chemotherapy with stem cell transplant is a method of giving high doses of chemotherapy and replacing blood-forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body’s blood cells.
At Yale we believe that the patient should be involved in all decision making and we help to guide them through this process as best we can so that they understand their options fully.

Testicular Cancer: Answering Your Questions